Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Revenue: 2011-2024

Historic Revenue for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $426.5 million.

  • Adma Biologics' Revenue rose 12.00% to $134.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $488.6 million, marking a year-over-year increase of 27.62%. This contributed to the annual value of $426.5 million for FY2024, which is 65.15% up from last year.
  • According to the latest figures from FY2024, Adma Biologics' Revenue is $426.5 million, which was up 65.15% from $258.2 million recorded in FY2023.
  • In the past 5 years, Adma Biologics' Revenue registered a high of $426.5 million during FY2024, and its lowest value of $42.2 million during FY2020.
  • For the 3-year period, Adma Biologics' Revenue averaged around $279.6 million, with its median value being $258.2 million (2023).
  • Data for Adma Biologics' Revenue shows a peak YoY soared of 91.72% (in 2021) over the last 5 years.
  • Adma Biologics' Revenue (Yearly) stood at $42.2 million in 2020, then soared by 91.72% to $80.9 million in 2021, then skyrocketed by 90.36% to $154.1 million in 2022, then spiked by 67.59% to $258.2 million in 2023, then spiked by 65.15% to $426.5 million in 2024.